CORMORANT ASSET MANAGEMENT, LP Holdings

CORMORANT ASSET MANAGEMENT, LP is an investment fund managing more than 1.43B US dollars. The largest holdings include Prometheus Biosciences, Apellis Pharmaceuticals and Design Therapeutics. In Q3 2022 the fund bought assets of total value of 345.87M US dollars and sold assets of total value of 88.04M US dollars.

$1.43B

portfolio value

+28.59%

quarter

-37.21%

1 year

-36.96%

3 years

-105.06%

5 years

CORMORANT ASSET MANAGEMENT, LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	39873000	3282000
Q2 2016	158806000	118782000
Q3 2016	159651000	120531000
Q4 2016	25508000	176776000
Q1 2017	69771000	108384000
Q2 2017	117564000	185996000
Q3 2017	130514000	192528000
Q4 2017	493816000	153028000
Q1 2018	341456000	17592000
Q2 2018	226984000	200060000
Q3 2018	185479000	26740000
Q4 2018	76667000	359474000
Q1 2019	472357000	123963000
Q2 2019	474125000	316041000
Q3 2019	57229000	231645000
Q4 2019	657890000	221490000
Q1 2020	287263000	778786000
Q2 2020	402412000	127415000
Q3 2020	258661000	203315000
Q4 2020	1032513000	14487000
Q1 2021	616776000	446607000
Q2 2021	295435000	924717000
Q3 2021	432285000	422642000
Q4 2021	72117000	766794000
Q1 2022	46453000	269979000
Q2 2022	159386000	44610000
Q3 2022	345865000	88043000

CORMORANT ASSET MANAGEMENT, LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 8.16% Portfolio value: 116.79M Avg. open price: $37.76 Current price: $37.72 P/L: -0.11% Sold -2.46% shares Q3 2022	share	8.16%	116.79M	$37.76	$37.72	-0.11%	Sold -2.46% shares Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 7.06% Portfolio value: 100.94M Avg. open price: $35.54 Current price: $49.41 P/L: +39.02% Bought +55.58% shares Q3 2022	share	7.06%	100.94M	$35.54	$49.41	+39.02%	Bought +55.58% shares Q3 2022
Biotechnology Design Therapeutics, Inc. Portfolio share: 5.84% Portfolio value: 83.6M Avg. open price: $21.74 Current price: $13.67 P/L: -37.11% Sold -9.09% shares Q3 2022	share	5.84%	83.6M	$21.74	$13.67	-37.11%	Sold -9.09% shares Q3 2022
Biotechnology Erasca, Inc. Portfolio share: 5.73% Portfolio value: 81.94M Avg. open price: $15.12 Current price: $7.28 P/L: -51.85% Bought 0.00% shares Q1 2022	share	5.73%	81.94M	$15.12	$7.28	-51.85%	Bought 0.00% shares Q1 2022
Biotechnology Arcellx, Inc. Portfolio share: 4.00% Portfolio value: 57.23M Avg. open price: $18.08 Current price: $19.45 P/L: +7.58% Bought +99.95% shares Q3 2022	share	4.00%	57.23M	$18.08	$19.45	+7.58%	Bought +99.95% shares Q3 2022
Biotechnology MoonLake Immunotherapeutics Portfolio share: 3.29% Portfolio value: 47.06M Avg. open price: N/A Current price: $10.07 P/L: N/A N/A Q2 2022	share	3.29%	47.06M	N/A	$10.07	N/A	N/A Q2 2022
Biotechnology Altimmune, Inc. Portfolio share: 3.07% Portfolio value: 43.96M Avg. open price: $11.7 Current price: $11.09 P/L: -5.21% Bought +14.76% shares Q3 2022	share	3.07%	43.96M	$11.7	$11.09	-5.21%	Bought +14.76% shares Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 2.81% Portfolio value: 40.15M Avg. open price: $60.07 Current price: $92.75 P/L: +54.40% Bought +91.67% shares Q3 2022	share	2.81%	40.15M	$60.07	$92.75	+54.40%	Bought +91.67% shares Q3 2022
Biotechnology Revolution Medicines, Inc. Portfolio share: 2.75% Portfolio value: 39.34M Avg. open price: $45.6 Current price: $24.32 P/L: -46.66% Sold -17.96% shares Q1 2022	share	2.75%	39.34M	$45.6	$24.32	-46.66%	Sold -17.96% shares Q1 2022
Biotechnology Aerovate Therapeutics, Inc. Portfolio share: 2.70% Portfolio value: 38.64M Avg. open price: $15.63 Current price: $18 P/L: +15.16% Bought +34.67% shares Q3 2022	share	2.70%	38.64M	$15.63	$18	+15.16%	Bought +34.67% shares Q3 2022
Biotechnology Gossamer Bio, Inc. Portfolio share: 2.68% Portfolio value: 38.31M Avg. open price: $9.09 Current price: $9.29 P/L: +2.22% Bought +1512.23% shares Q3 2022	share	2.68%	38.31M	$9.09	$9.29	+2.22%	Bought +1512.23% shares Q3 2022
Biotechnology Tarsus Pharmaceuticals, Inc. Portfolio share: 2.36% Portfolio value: 33.75M Avg. open price: $16.46 Current price: $16.74 P/L: +1.70% Bought +5.14% shares Q3 2022	share	2.36%	33.75M	$16.46	$16.74	+1.70%	Bought +5.14% shares Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 2.36% Portfolio value: 33.74M Avg. open price: $126.51 Current price: $226.95 P/L: +79.39% Bought +20.00% shares Q3 2022	share	2.36%	33.74M	$126.51	$226.95	+79.39%	Bought +20.00% shares Q3 2022
Biotechnology Avidity Biosciences, Inc. Portfolio share: 2.30% Portfolio value: 32.85M Avg. open price: N/A Current price: $11.18 P/L: N/A Sold -6.94% shares Q4 2021	share	2.30%	32.85M	N/A	$11.18	N/A	Sold -6.94% shares Q4 2021
Biotechnology Immuneering Corporation Portfolio share: 2.29% Portfolio value: 32.73M Avg. open price: $26.55 Current price: $6.11 P/L: -76.99% Sold -0.71% shares Q2 2022	share	2.29%	32.73M	$26.55	$6.11	-76.99%	Sold -0.71% shares Q2 2022
Biotechnology Biomea Fusion, Inc. Portfolio share: 2.17% Portfolio value: 31.01M Avg. open price: N/A Current price: $6.77 P/L: N/A N/A Q2 2021	share	2.17%	31.01M	N/A	$6.77	N/A	N/A Q2 2021
Biotechnology Edgewise Therapeutics, Inc. Portfolio share: 2.10% Portfolio value: 30.03M Avg. open price: $21.64 Current price: $8.83 P/L: -59.20% Sold -20.73% shares Q3 2022	share	2.10%	30.03M	$21.64	$8.83	-59.20%	Sold -20.73% shares Q3 2022
Biotechnology Biohaven Ltd. Portfolio share: 1.95% Portfolio value: 27.95M Avg. open price: $47.81 Current price: $16.32 P/L: -65.86% Bought +131.12% shares Q2 2022	share	1.95%	27.95M	$47.81	$16.32	-65.86%	Bought +131.12% shares Q2 2022
Biotechnology Ventyx Biosciences, Inc. Portfolio share: 1.90% Portfolio value: 27.25M Avg. open price: $12.23 Current price: $28.09 P/L: +129.68% Bought 0.00% shares Q3 2022	share	1.90%	27.25M	$12.23	$28.09	+129.68%	Bought 0.00% shares Q3 2022
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 1.88% Portfolio value: 26.86M Avg. open price: $16.97 Current price: $26.84 P/L: +58.20% Bought +49.29% shares Q3 2022	share	1.88%	26.86M	$16.97	$26.84	+58.20%	Bought +49.29% shares Q3 2022
Biotechnology Monte Rosa Therapeutics, Inc. Portfolio share: 1.71% Portfolio value: 24.45M Avg. open price: N/A Current price: $9.43 P/L: N/A Sold -0.28% shares Q2 2022	share	1.71%	24.45M	N/A	$9.43	N/A	Sold -0.28% shares Q2 2022
Biotechnology GreenLight Biosciences Holdings Portfolio share: 1.66% Portfolio value: 23.80M Avg. open price: $2.73 Current price: $1.29 P/L: -52.79% Bought +47.42% shares Q3 2022	share	1.66%	23.80M	$2.73	$1.29	-52.79%	Bought +47.42% shares Q3 2022
Medical Devices Axonics, Inc. Portfolio share: 1.59% Portfolio value: 22.69M Avg. open price: N/A Current price: $67.47 P/L: N/A Sold -53.50% shares Q2 2021	share	1.59%	22.69M	N/A	$67.47	N/A	Sold -53.50% shares Q2 2021
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 1.55% Portfolio value: 22.10M Avg. open price: $105.11 Current price: $122.96 P/L: +16.98% N/A Q3 2022	share	1.55%	22.10M	$105.11	$122.96	+16.98%	N/A Q3 2022
Biotechnology Cogent Biosciences, Inc. Portfolio share: 1.51% Portfolio value: 21.63M Avg. open price: $9.02 Current price: $12.5 P/L: +38.58% Bought +93.33% shares Q3 2022	share	1.51%	21.63M	$9.02	$12.5	+38.58%	Bought +93.33% shares Q3 2022
Biotechnology Verve Therapeutics, Inc. Portfolio share: 1.44% Portfolio value: 20.61M Avg. open price: $47 Current price: $21.42 P/L: -54.43% Sold -14.37% shares Q3 2022	share	1.44%	20.61M	$47	$21.42	-54.43%	Sold -14.37% shares Q3 2022
Biotechnology Adicet Bio, Inc. Portfolio share: 1.39% Portfolio value: 19.90M Avg. open price: $19.97 Current price: $20.2 P/L: +1.15% Sold -22.22% shares Q3 2022	share	1.39%	19.90M	$19.97	$20.2	+1.15%	Sold -22.22% shares Q3 2022
Biotechnology Arcutis Biotherapeutics, Inc. Portfolio share: 1.34% Portfolio value: 19.11M Avg. open price: N/A Current price: $17.35 P/L: N/A N/A Q3 2022	share	1.34%	19.11M	N/A	$17.35	N/A	N/A Q3 2022
Biotechnology Amylyx Pharmaceuticals, Inc. Portfolio share: 1.20% Portfolio value: 17.17M Avg. open price: N/A Current price: $38.55 P/L: N/A N/A Q3 2022	share	1.20%	17.17M	N/A	$38.55	N/A	N/A Q3 2022
Biotechnology BioAtla, Inc. Portfolio share: 1.17% Portfolio value: 16.79M Avg. open price: $15.28 Current price: $10.52 P/L: -31.14% Bought +7.01% shares Q3 2022	share	1.17%	16.79M	$15.28	$10.52	-31.14%	Bought +7.01% shares Q3 2022
Biotechnology Pliant Therapeutics, Inc. Portfolio share: 1.14% Portfolio value: 16.35M Avg. open price: $8.01 Current price: $17 P/L: +112.23% Bought +62.27% shares Q3 2022	share	1.14%	16.35M	$8.01	$17	+112.23%	Bought +62.27% shares Q3 2022
VECTIVBIO HLDG AG Portfolio share: 1.06% Portfolio value: 15.22M Avg. open price: N/A Current price: N/A P/L: N/A Sold -10.69% shares Q3 2022	share	1.06%	15.22M	N/A	N/A	N/A	Sold -10.69% shares Q3 2022
Biotechnology Tango Therapeutics, Inc. Portfolio share: 1.04% Portfolio value: 14.90M Avg. open price: N/A Current price: $7.69 P/L: N/A Sold -8.67% shares Q3 2022	share	1.04%	14.90M	N/A	$7.69	N/A	Sold -8.67% shares Q3 2022
Biotechnology BridgeBio Pharma, Inc. Portfolio share: 1.02% Portfolio value: 14.60M Avg. open price: $35.05 Current price: $9.17 P/L: -73.84% Sold -6.36% shares Q2 2022	share	1.02%	14.60M	$35.05	$9.17	-73.84%	Sold -6.36% shares Q2 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 1.00% Portfolio value: 14.34M Avg. open price: N/A Current price: $38.12 P/L: N/A Sold -26.00% shares Q3 2022	share	1.00%	14.34M	N/A	$38.12	N/A	Sold -26.00% shares Q3 2022
Biotechnology Stoke Therapeutics, Inc. Portfolio share: 0.98% Portfolio value: 13.96M Avg. open price: $21.49 Current price: $7.16 P/L: -66.68% Sold -8.00% shares Q1 2022	share	0.98%	13.96M	$21.49	$7.16	-66.68%	Sold -8.00% shares Q1 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 0.97% Portfolio value: 13.86M Avg. open price: $21.02 Current price: $19.03 P/L: -9.48% Sold -10.32% shares Q4 2021	share	0.97%	13.86M	$21.02	$19.03	-9.48%	Sold -10.32% shares Q4 2021
Biotechnology Rain Therapeutics Inc. Portfolio share: 0.79% Portfolio value: 11.35M Avg. open price: N/A Current price: $6.83 P/L: N/A Sold -11.42% shares Q3 2021	share	0.79%	11.35M	N/A	$6.83	N/A	Sold -11.42% shares Q3 2021
Biotechnology Astria Therapeutics, Inc. Portfolio share: 0.76% Portfolio value: 10.84M Avg. open price: $3 Current price: $10.32 P/L: +244.00% Bought +300.00% shares Q3 2022	share	0.76%	10.84M	$3	$10.32	+244.00%	Bought +300.00% shares Q3 2022
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 0.68% Portfolio value: 9.70M Avg. open price: N/A Current price: $369.29 P/L: N/A N/A Q3 2022	share	0.68%	9.70M	N/A	$369.29	N/A	N/A Q3 2022
Biotechnology Pharvaris N.V. Portfolio share: 0.65% Portfolio value: 9.26M Avg. open price: $18.6 Current price: $2.02 P/L: -89.14% Bought +5.37% shares Q3 2022	share	0.65%	9.26M	$18.6	$2.02	-89.14%	Bought +5.37% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.63% Portfolio value: 8.97M Avg. open price: N/A Current price: $21.89 P/L: N/A N/A Q3 2022	put	0.63%	8.97M	N/A	$21.89	N/A	N/A Q3 2022
Biotechnology Atea Pharmaceuticals, Inc. Portfolio share: 0.62% Portfolio value: 8.80M Avg. open price: N/A Current price: $4.67 P/L: N/A Sold -7.88% shares Q1 2022	share	0.62%	8.80M	N/A	$4.67	N/A	Sold -7.88% shares Q1 2022
Biotechnology Centessa Pharmaceuticals plc Portfolio share: 0.55% Portfolio value: 7.93M Avg. open price: $8.97 Current price: $3.93 P/L: -56.19% Sold -32.61% shares Q3 2022	share	0.55%	7.93M	$8.97	$3.93	-56.19%	Sold -32.61% shares Q3 2022
Biotechnology Longboard Pharmaceuticals, Inc. Portfolio share: 0.55% Portfolio value: 7.88M Avg. open price: N/A Current price: $4.75 P/L: N/A Sold -6.82% shares Q3 2022	share	0.55%	7.88M	N/A	$4.75	N/A	Sold -6.82% shares Q3 2022
Biotechnology GH Research PLC Portfolio share: 0.48% Portfolio value: 6.89M Avg. open price: N/A Current price: $11.4 P/L: N/A Sold -2.48% shares Q3 2022	share	0.48%	6.89M	N/A	$11.4	N/A	Sold -2.48% shares Q3 2022
Biotechnology ALX Oncology Holdings Inc. Portfolio share: 0.48% Portfolio value: 6.81M Avg. open price: $55.8 Current price: $11.92 P/L: -78.64% Sold -6.56% shares Q1 2022	share	0.48%	6.81M	$55.8	$11.92	-78.64%	Sold -6.56% shares Q1 2022
Biotechnology Tyra Biosciences, Inc. Portfolio share: 0.46% Portfolio value: 6.54M Avg. open price: N/A Current price: $6.89 P/L: N/A Sold -1.77% shares Q2 2022	share	0.46%	6.54M	N/A	$6.89	N/A	Sold -1.77% shares Q2 2022
Biotechnology Poseida Therapeutics, Inc. Portfolio share: 0.46% Portfolio value: 6.53M Avg. open price: N/A Current price: $5.1 P/L: N/A N/A Q3 2022	share	0.46%	6.53M	N/A	$5.1	N/A	N/A Q3 2022
Biotechnology IDEAYA Biosciences, Inc. Portfolio share: 0.44% Portfolio value: 6.24M Avg. open price: N/A Current price: $17.77 P/L: N/A N/A Q3 2022	share	0.44%	6.24M	N/A	$17.77	N/A	N/A Q3 2022
Biotechnology Olema Pharmaceuticals, Inc. Portfolio share: 0.40% Portfolio value: 5.74M Avg. open price: N/A Current price: $2.79 P/L: N/A Sold -4.05% shares Q1 2022	share	0.40%	5.74M	N/A	$2.79	N/A	Sold -4.05% shares Q1 2022
Biotechnology Vigil Neuroscience, Inc. Portfolio share: 0.39% Portfolio value: 5.61M Avg. open price: N/A Current price: $12 P/L: N/A N/A Q1 2022	share	0.39%	5.61M	N/A	$12	N/A	N/A Q1 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 0.36% Portfolio value: 5.16M Avg. open price: $79.67 Current price: $119.41 P/L: +49.88% Sold -70.59% shares Q4 2021	share	0.36%	5.16M	$79.67	$119.41	+49.88%	Sold -70.59% shares Q4 2021
Biotechnology Keros Therapeutics, Inc. Portfolio share: 0.26% Portfolio value: 3.76M Avg. open price: N/A Current price: $50 P/L: N/A Sold -33.33% shares Q1 2022	share	0.26%	3.76M	N/A	$50	N/A	Sold -33.33% shares Q1 2022
Biotechnology Eledon Pharmaceuticals, Inc. Portfolio share: 0.24% Portfolio value: 3.37M Avg. open price: N/A Current price: $2.43 P/L: N/A Sold -6.25% shares Q3 2022	share	0.24%	3.37M	N/A	$2.43	N/A	Sold -6.25% shares Q3 2022
Biotechnology Akouos, Inc. Portfolio share: 0.19% Portfolio value: 2.66M Avg. open price: $22.5 Current price: $13.29 P/L: -40.93% Sold -21.10% shares Q2 2021	share	0.19%	2.66M	$22.5	$13.29	-40.93%	Sold -21.10% shares Q2 2021
Biotechnology Ambrx Biopharma Inc. Portfolio share: 0.18% Portfolio value: 2.52M Avg. open price: N/A Current price: $0.52 P/L: N/A Sold -6.03% shares Q3 2022	share	0.18%	2.52M	N/A	$0.52	N/A	Sold -6.03% shares Q3 2022
Biotechnology Talaris Therapeutics, Inc. Portfolio share: 0.17% Portfolio value: 2.36M Avg. open price: N/A Current price: $1.42 P/L: N/A Sold -23.33% shares Q3 2022	share	0.17%	2.36M	N/A	$1.42	N/A	Sold -23.33% shares Q3 2022
Biotechnology Elevation Oncology, Inc. Portfolio share: 0.15% Portfolio value: 2.20M Avg. open price: $2.52 Current price: $0.95 P/L: -62.30% Sold -1.57% shares Q3 2022	share	0.15%	2.20M	$2.52	$0.95	-62.30%	Sold -1.57% shares Q3 2022
Biotechnology Y-mAbs Therapeutics, Inc. Portfolio share: 0.15% Portfolio value: 2.16M Avg. open price: $26.58 Current price: $4.43 P/L: -83.33% Sold -50.00% shares Q1 2022	share	0.15%	2.16M	$26.58	$4.43	-83.33%	Sold -50.00% shares Q1 2022
Biotechnology Icosavax, Inc. Portfolio share: 0.14% Portfolio value: 2.03M Avg. open price: $7.04 Current price: $3.19 P/L: -54.69% Sold -1.16% shares Q3 2022	share	0.14%	2.03M	$7.04	$3.19	-54.69%	Sold -1.16% shares Q3 2022
Biotechnology Galecto, Inc. Portfolio share: 0.13% Portfolio value: 1.92M Avg. open price: N/A Current price: $1.44 P/L: N/A Sold -11.34% shares Q4 2021	share	0.13%	1.92M	N/A	$1.44	N/A	Sold -11.34% shares Q4 2021
Biotechnology X4 Pharmaceuticals, Inc. Portfolio share: 0.10% Portfolio value: 1.42M Avg. open price: $8.78 Current price: $1.29 P/L: -85.30% Bought +698.86% shares Q3 2022	share	0.10%	1.42M	$8.78	$1.29	-85.30%	Bought +698.86% shares Q3 2022
Biotechnology Pyxis Oncology, Inc. Portfolio share: 0.09% Portfolio value: 1.31M Avg. open price: $2.38 Current price: $1.29 P/L: -45.80% Bought 0.00% shares Q3 2022	share	0.09%	1.31M	$2.38	$1.29	-45.80%	Bought 0.00% shares Q3 2022
Biotechnology Autolus Therapeutics plc Portfolio share: 0.06% Portfolio value: 839K Avg. open price: N/A Current price: $3.22 P/L: N/A Sold -7.11% shares Q2 2021	share	0.06%	839K	N/A	$3.22	N/A	Sold -7.11% shares Q2 2021
Biotechnology Cabaletta Bio, Inc. Portfolio share: 0.05% Portfolio value: 750K Avg. open price: N/A Current price: $4.97 P/L: N/A Sold -28.37% shares Q4 2021	share	0.05%	750K	N/A	$4.97	N/A	Sold -28.37% shares Q4 2021
Biotechnology Chemomab Therapeutics Ltd. Portfolio share: 0.05% Portfolio value: 718K Avg. open price: $3.7 Current price: $2.05 P/L: -44.59% Bought 0.00% shares Q3 2022	share	0.05%	718K	$3.7	$2.05	-44.59%	Bought 0.00% shares Q3 2022
Biotechnology Gelesis Holdings, Inc. Portfolio share: 0.05% Portfolio value: 676K Avg. open price: N/A Current price: $0.44 P/L: N/A Sold -0.00% shares Q3 2022	share	0.05%	676K	N/A	$0.44	N/A	Sold -0.00% shares Q3 2022
Biotechnology Graphite Bio, Inc. Portfolio share: 0.04% Portfolio value: 633K Avg. open price: N/A Current price: $3.59 P/L: N/A Sold -1.78% shares Q2 2022	share	0.04%	633K	N/A	$3.59	N/A	Sold -1.78% shares Q2 2022
Biotechnology Harpoon Therapeutics, Inc. Portfolio share: 0.04% Portfolio value: 524K Avg. open price: N/A Current price: $0.72 P/L: N/A Sold -5.26% shares Q2 2021	share	0.04%	524K	N/A	$0.72	N/A	Sold -5.26% shares Q2 2021
Biotechnology Atreca, Inc. Portfolio share: 0.04% Portfolio value: 501K Avg. open price: $3.02 Current price: $1 P/L: -67.05% Sold -60.12% shares Q2 2022	share	0.04%	501K	$3.02	$1	-67.05%	Sold -60.12% shares Q2 2022
Biotechnology Orchard Therapeutics plc Portfolio share: 0.01% Portfolio value: 128K Avg. open price: $16.22 Current price: $0.45 P/L: -97.23% Sold -26.71% shares Q1 2020	share	0.01%	128K	$16.22	$0.45	-97.23%	Sold -26.71% shares Q1 2020
Biotechnology IMV Inc. Portfolio share: 0.01% Portfolio value: 122K Avg. open price: N/A Current price: $0.3 P/L: N/A N/A Q4 2020	share	0.01%	122K	N/A	$0.3	N/A	N/A Q4 2020
SPDR S&P Biotech ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $108.07 Current price: $82.88 P/L: -23.31% Sold -100.00% shares Q3 2022	call	0.00%	0	$108.07	$82.88	-23.31%	Sold -100.00% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $36.66 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$36.66	N/A	Sold -100.00% shares Q3 2022
Biotechnology AnaptysBio, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $29.55 Current price: $28.65 P/L: -3.03% Sold -100.00% shares Q3 2022	share	0.00%	0	$29.55	$28.65	-3.03%	Sold -100.00% shares Q3 2022
Biotechnology Renovacor, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $3.2 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$3.2	N/A	Sold -100.00% shares Q3 2022
Biotechnology SpringWorks Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $24.25 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$24.25	N/A	Sold -100.00% shares Q3 2022
Biotechnology Forma Therapeutics Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $46.92 Current price: $20.01 P/L: -57.35% Sold -100.00% shares Q3 2022	share	0.00%	0	$46.92	$20.01	-57.35%	Sold -100.00% shares Q3 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $24.92 Current price: $44.04 P/L: +76.73% Sold -100.00% shares Q3 2022	share	0.00%	0	$24.92	$44.04	+76.73%	Sold -100.00% shares Q3 2022
Biotechnology Kezar Life Sciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $7.07 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$7.07	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $105.21 Current price: $98.48 P/L: -6.40% Sold -100.00% shares Q3 2022	share	0.00%	0	$105.21	$98.48	-6.40%	Sold -100.00% shares Q3 2022
Biotechnology MeiraGTx Holdings plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $6.49 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$6.49	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $61.19 Current price: $54.25 P/L: -11.34% Sold -100.00% shares Q3 2022	share	0.00%	0	$61.19	$54.25	-11.34%	Sold -100.00% shares Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $23.86 Current price: $51.99 P/L: +117.88% Sold -100.00% shares Q3 2022	share	0.00%	0	$23.86	$51.99	+117.88%	Sold -100.00% shares Q3 2022
Biotechnology Axsome Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $77.29 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$77.29	N/A	Sold -100.00% shares Q3 2022
Biotechnology Turning Point Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $69.09 Current price: $76.01 P/L: +10.02% Sold -100.00% shares Q3 2022	share	0.00%	0	$69.09	$76.01	+10.02%	Sold -100.00% shares Q3 2022

Showing TOP 87 CORMORANT ASSET MANAGEMENT, LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of CORMORANT ASSET MANAGEMENT, LP?

The biggest position of the CORMORANT ASSET MANAGEMENT, LP is Prometheus Biosciences, Inc. (RXDX) with 8.16% portfolio share worth of 116.79M US dollars.

Top 5 CORMORANT ASSET MANAGEMENT, LP's holdings represent 30.79% of the portfolio:

Prometheus Biosciences, Inc. (RXDX) – 8.16%
Apellis Pharmaceuticals, Inc. (APLS) – 7.06%
Design Therapeutics, Inc. (DSGN) – 5.84%
Erasca, Inc. (ERAS) – 5.73%
Arcellx, Inc. (ACLX) – 4%

Who is the portfolio manager of CORMORANT ASSET MANAGEMENT, LP?

The portfolio manager of the CORMORANT ASSET MANAGEMENT, LP is .

What is the total asset value of the CORMORANT ASSET MANAGEMENT, LP portfolio?

CORMORANT ASSET MANAGEMENT, LP total asset value (portfolio value) is 1.43B US dollars.

Who is ?

is the portfolio manager of the CORMORANT ASSET MANAGEMENT, LP.

What is (CORMORANT ASSET MANAGEMENT, LP) fund performance?

CORMORANT ASSET MANAGEMENT, LP's quarterly performance is +28.59%, annualy -37.21%. In the past 3 years, the value of 's portfolio has decreased by -37%. In the past 5 years, the value of the portfolio has decreased by -105%.

What is the CORMORANT ASSET MANAGEMENT, LP CIK?

CORMORANT ASSET MANAGEMENT, LP's Central Index Key is 0001583977 .

CORMORANT ASSET MANAGEMENT, LP Holdings

CORMORANT ASSET MANAGEMENT, LP portfolio value:

CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:

CORMORANT ASSET MANAGEMENT, LP 1 year portfolio value change:

CORMORANT ASSET MANAGEMENT, LP 3 years portfolio value change:

CORMORANT ASSET MANAGEMENT, LP 5 years portfolio value change: